Mainz Biomed Bv Stock Market Value
| MYNZ Stock | USD 5.66 0.08 1.39% |
| Symbol | Mainz |
Mainz Biomed BV Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mainz Biomed. If investors know Mainz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mainz Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (44.40) | Revenue Per Share | Quarterly Revenue Growth 0.046 | Return On Assets | Return On Equity |
The market value of Mainz Biomed BV is measured differently than its book value, which is the value of Mainz that is recorded on the company's balance sheet. Investors also form their own opinion of Mainz Biomed's value that differs from its market value or its book value, called intrinsic value, which is Mainz Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mainz Biomed's market value can be influenced by many factors that don't directly affect Mainz Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mainz Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mainz Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mainz Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mainz Biomed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mainz Biomed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mainz Biomed.
| 04/07/2023 |
| 02/25/2025 |
If you would invest 0.00 in Mainz Biomed on April 7, 2023 and sell it all today you would earn a total of 0.00 from holding Mainz Biomed BV or generate 0.0% return on investment in Mainz Biomed over 690 days. Mainz Biomed is related to or competes with Applied DNA, Neuronetics, Prenetics Global, Fonar, MDxHealth, Inotiv, and Star Equity. Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic and research use only te... More
Mainz Biomed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mainz Biomed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mainz Biomed BV upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.08 | |||
| Information Ratio | 0.1228 | |||
| Maximum Drawdown | 3385.75 | |||
| Value At Risk | (14.48) | |||
| Potential Upside | 15.75 |
Mainz Biomed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mainz Biomed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mainz Biomed's standard deviation. In reality, there are many statistical measures that can use Mainz Biomed historical prices to predict the future Mainz Biomed's volatility.| Risk Adjusted Performance | 0.1002 | |||
| Jensen Alpha | 51.13 | |||
| Total Risk Alpha | 53.53 | |||
| Sortino Ratio | 5.6 | |||
| Treynor Ratio | 0.7659 |
Mainz Biomed BV Backtested Returns
Mainz Biomed is out of control given 3 months investment horizon. Mainz Biomed BV has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 16.97% are justified by taking the suggested risk. Use Mainz Biomed BV Risk Adjusted Performance of 0.1002, downside deviation of 9.08, and Mean Deviation of 100.28 to evaluate company specific risk that cannot be diversified away. Mainz Biomed holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 66.34, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mainz Biomed will likely underperform. Use Mainz Biomed BV jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Mainz Biomed BV.
Auto-correlation | -0.55 |
Good reverse predictability
Mainz Biomed BV has good reverse predictability. Overlapping area represents the amount of predictability between Mainz Biomed time series from 7th of April 2023 to 17th of March 2024 and 17th of March 2024 to 25th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mainz Biomed BV price movement. The serial correlation of -0.55 indicates that about 55.0% of current Mainz Biomed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 4.87 |
Mainz Biomed BV lagged returns against current returns
Autocorrelation, which is Mainz Biomed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mainz Biomed's stock expected returns. We can calculate the autocorrelation of Mainz Biomed returns to help us make a trade decision. For example, suppose you find that Mainz Biomed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mainz Biomed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mainz Biomed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mainz Biomed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mainz Biomed stock over time.
Current vs Lagged Prices |
| Timeline |
Mainz Biomed Lagged Returns
When evaluating Mainz Biomed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mainz Biomed stock have on its future price. Mainz Biomed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mainz Biomed autocorrelation shows the relationship between Mainz Biomed stock current value and its past values and can show if there is a momentum factor associated with investing in Mainz Biomed BV.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.